Matches in SemOpenAlex for { <https://semopenalex.org/work/W939120930> ?p ?o ?g. }
Showing items 1 to 27 of
27
with 100 items per page.
- W939120930 endingPage "829" @default.
- W939120930 startingPage "827" @default.
- W939120930 abstract "目的；观察去唾液酸糖蛋白受体导向药物Ｌ－ＨＡＳ－Ａｒａ－ＡＭＰ的抗ＨＢＶ的临床疗效。方法：应用５ｄ和２８ｄ疗程治疗慢性乙型肝炎２９例，以Ａｒａ－ＡＭＰ治疗２７例为对照。结果：Ｌ－ＨＳＡ－Ａｒａ－ＡＭＰ ５ｄ疗程，１０例ＨＢｅＡｇ阳性阴转３例，８例ＨＢＶ－ＤＮＡ阳性阴转４例。２８ｄ疗程ＨＢｅＡｇ阴转率３１．６％，ＨＢｅＡｇ滴度下降率４７．４％，有治疗效应者７９．０％．；ＨＢＶ－ＤＮＡ阴转率３１．６％" @default.
- W939120930 created "2016-06-24" @default.
- W939120930 creator A5056480530 @default.
- W939120930 creator A5090000239 @default.
- W939120930 date "1999-01-01" @default.
- W939120930 modified "2023-09-23" @default.
- W939120930 title "受体导向药物L-HAS-Ara-AMP抗HBV效应的临床研究" @default.
- W939120930 hasPublicationYear "1999" @default.
- W939120930 type Work @default.
- W939120930 sameAs 939120930 @default.
- W939120930 citedByCount "0" @default.
- W939120930 crossrefType "journal-article" @default.
- W939120930 hasAuthorship W939120930A5056480530 @default.
- W939120930 hasAuthorship W939120930A5090000239 @default.
- W939120930 hasConcept C41008148 @default.
- W939120930 hasConceptScore W939120930C41008148 @default.
- W939120930 hasIssue "12" @default.
- W939120930 hasLocation W9391209301 @default.
- W939120930 hasOpenAccess W939120930 @default.
- W939120930 hasPrimaryLocation W9391209301 @default.
- W939120930 hasVolume "8" @default.
- W939120930 isParatext "false" @default.
- W939120930 isRetracted "false" @default.
- W939120930 magId "939120930" @default.
- W939120930 workType "article" @default.